Journal of the Chinese Medical Association

Aims & Scope

Journal of the Chinese Medical Association, previously known as the Chinese Medical Journal (Taipei), has a long history of publishing scientific papers and has continuously made substantial contribution in the understanding and progress of a broad range of biomedical sciences.

It is published monthly by Wolters Kluwer Health and indexed in Science Citation Index Expanded (SCIE), MEDLINE®, Index Medicus, EMBASE, CAB Abstracts, Sociedad Iberoamericana de Informacion Cientifica (SIIC) Data Bases, ScienceDirect, Scopus and Global Health.

JCMA is the official and open access journal of the Chinese Medical Association, Taipei, Taiwan, Republic of China and is an international forum for scholarly reports in medicine, surgery, dentistry and basic research in biomedical science.

As a vehicle of communication and education among physicians and scientists, the journal is open to the use of diverse methodological approaches.

Reports of professional practice will need to demonstrate academic robustness and scientific rigor.

Outstanding scholars are invited to give their update reviews on the perspectives of the evidence-based science in the related research field.

Article types accepted include review articles, original articles, case reports, brief communications and letters to the editor

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.4
2024	1.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.425

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	54

Journal Rank

Year	Value
2024	13244

Journal Citation Indicator

Year	Value
2024	1041

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Bacterial biofilm and associated infections

  Citation: 1298

  Authors: Muhsin, Wisal, Saadia, Fazal, Muhammad, Muhammad Asif, Tahir, Muhammad, Muhammad, Muhammad Atif

• The outbreak of COVID-19: An overview

  Citation: 1054

  Authors: Yi-Chi, Ching-Sung, Yu-Jiun

• Wound healing

  Citation: 705

  Authors: Peng-Hui, Ben-Shian, Huann-Cheng, Chang-Ching, Yi-Jen

• ChatGPT and other artificial intelligence applications speed up scientific writing

  Citation: 172

  Authors: Tzeng-Ji

• 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension

  Citation: 164

  Authors: Chern-En, Tzung-Dau, Kwo-Chang, Tsung-Hsien, Hung-I, Chung-Yin, Yih-Jer, Wei-Chuan, Ting-Hsing, Chen-Huan, Pao-Hsien, Chia-Lun, Ping-Yen, Shih-Hsien, Hao-Min, Kang-Ling, Yi-Heng, Fu-Tien, Jyh-Hong, Wen-Jone, San-Jou, Shing-Jong

• Gastrointestinal and liver manifestations in patients with COVID-19

  Citation: 156

  Authors: I-Cheng, Teh-Ia, Yi-Hsiang

• Clinical manifestation and disease progression in COVID-19 infection

  Citation: 152

  Authors: Ping-Hsing, Wei-Yi, Yi-Ying, Yung-Hung, Yi-Tsung, Hsiao-Kang, Yuh-Min, Yi-Chun, Li-Chiao, Shew-Dan, Kao-Jung, Cheng-Hsuan, Shih-Chieh, Fu-Der, Yi-Ping

• Chromobacterium violaceum infection: A clinical review of an important but neglected infection

  Citation: 128

  Authors: Ching-Huei, Yi-Hwei

• Potential therapeutic agents against COVID-19: What we know so far

  Citation: 125

  Authors: Chih-Chia, Mei-Yu, Wan-Shin, Yuh-Lih

• Screening for Anti-lipase Properties of 37 Traditional Chinese Medicinal Herbs

  Citation: 106

  Authors: Cheng-Dong, Ya-Qing, Jin-Ming, Zhi-Gang

---